140425-59-8

Basic information

• Product Name: Benzoic acid, 2-[(2-nitrophenyl)thio]-, ethyl ester
• CAS NO: 140425-59-8
• Molecular Formula: C15H13NO4S
• Molecular Weight: 303.339
• Mol File: 140425-59-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-[(2-nitrophenyl)thio]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-[(2-nitrophenyl)thio]-, ethyl ester(140425-59-8)
• EPA Substance Registry System: Benzoic acid, 2-[(2-nitrophenyl)thio]-, ethyl ester(140425-59-8)

Safety Data

• Hazardous Substances Data: 140425-59-8(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 19806-43-0 2?(2?nitrophenylsulfanyl)benzoic acid 
• 1493-27-2 ortho-nitrofluorobenzene 
• 147-93-3 Thiosalicylic acid 
• 577-19-5 2-nitrophenyl bromide 
• 4892-02-8 Methyl thiosalicylate 
• 88-73-3 2-Chloronitrobenzene 
• 33441-56-4 ethyl 2-mercaptobenzoate 

Downstream Products

• 19806-43-0 2?(2?nitrophenylsulfanyl)benzoic acid 
• 252731-18-3 2-(N-methylcarbamoyl)phenyl 2-nitrophenyl sulfide 
• 95906-78-8 2-(2'-nitrophenylthio)benzoic acid chloride 
• 860778-57-0 N-methyl-2-(2'-aminophenylthio)benzamide 
• 853180-71-9 N-methyl-2-(2'-aminophenylthio)benzylamine 

Relevant articles and documents

A process for the preparation of intermediates quetiapine (by machine translation)

The invention discloses a preparation method for a quetiapine intermediate. The preparation method comprises: taking thiosalicylic acid as an initial raw material to prepare 2-nitro-2'-carboxyldiphenyl sulfide, esterifying and reducing, and then performing intramolecular amino-ester exchange reaction for cyclization, so as to obtain the quetiapine intermediate 10,11-dihydro-11-oxodibenzo[b,f][1,4]thiazepine. The preparation method is simple, the target product is high in purity, the reaction yield is relatively high, the production cost is effectively reduced, and industrialized production of the high-purity quetiapine intermediate is facilitated to be realized.

TETRAZOLE DERIVATIVES AND DRUGS

A compound of the formula [I] useful for treating allergic symptoms, cardiovascular disorders, cerebrovascular disorders, inflammation or other conditions mediated by SRS-A in humans and animals is disclosed. STR1